Contact

All Stories

  1. Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana

    Article • PLoS ONE, March 2024, PLOS

    Professor Sandro Vento

  2. Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV

    Article • AIDS Research and Human Retroviruses, February 2024, Mary Ann Liebert Inc

    Professor Sandro Vento

  3. Acute liver failure in low-income and middle-income countries

    Article • The Lancet Gastroenterology & Hepatology, November 2023, Elsevier

    Professor Sandro Vento

  4. HIV-1 RNA levels in semen of people on ‘short-cycle’ antiretroviral therapy

    Article • Journal of Antimicrobial Chemotherapy, June 2023, Oxford University Press (OUP)

    Professor Sandro Vento

  5. Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients

    Article • Journal of Chemotherapy, April 2023, Taylor & Francis

    Professor Sandro Vento

  6. Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design

    Article • Health Science Reports, February 2023, Wiley

    Professor Sandro Vento

  7. Medicine should be learned in a conducive environment

    Article • The Lancet, January 2023, Elsevier

    Professor Sandro Vento

  8. Global research profile on monkeypox-related literature (1962–2022): A bibliometric analysis

    Article • Narra J, December 2022, Narra T

    Professor Sandro Vento

  9. Monkeypox: Immune response, vaccination and preventive efforts

    Article • Narra J, October 2022, Narra T

    Professor Sandro Vento, Mr Seyi Samson Enitan , Professor Yousef Khader, Dr. Robert Jeffrey Edwards

  10. Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients

    Article • AIDS Research and Human Retroviruses, October 2022, Mary Ann Liebert Inc

    Professor Sandro Vento

  11. Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, Indonesia

    Article • Narra J, August 2022, Narra T

    Professor Yousef Khader, Professor Sandro Vento, Prof. Mudatsir, PhD., M.MSc

  12. Acute severe hepatitis of unknown etiology in children: A mini-review

    Article • Narra J, June 2022, Narra T

    Professor Yousef Khader, Professor Sandro Vento

  13. Global multi-stakeholder endorsement of the MAFLD definition

    Article • The Lancet Gastroenterology & Hepatology, May 2022, Elsevier

    Dr Feliciano C Paquissi, Professor Sandro Vento, Dr. Francesca Cainelli, Prof. Dr. Mahmoud ElFiky

  14. Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID‐19 infections?

    Article • Journal of Medical Virology, April 2022, Wiley

    Professor Sandro Vento

  15. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries

    Article • Journal of Global Health, April 2022, Edinburgh University Global Health Society

    Professor Sandro Vento

  16. Chronic liver diseases must be reduced worldwide: it is time to act

    Article • The Lancet Global Health, April 2022, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  17. Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan

    Article • PLoS ONE, December 2021, PLOS

    Professor Sandro Vento

  18. Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapy

    Article • Journal of Antimicrobial Chemotherapy, November 2021, Oxford University Press (OUP)

    Professor Sandro Vento

  19. Prevalence of liver fibrosis using transient elastography in the general population in Cambodia: a pilot study

    Article • European Journal of Gastroenterology & Hepatology, July 2021, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  20. Mini-review: Silico-tuberculosis

    Article • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, May 2021, Elsevier

    Professor Sandro Vento

  21. Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection

    Article • International Journal of Antimicrobial Agents, March 2021, Elsevier

    Professor Sandro Vento

  22. Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor

    Article • International Journal of STD & AIDS, October 2020, SAGE Publications

    Professor Sandro Vento

  23. Violence Against Healthcare Workers: A Worldwide Phenomenon With Serious Consequences

    Article • Frontiers in Public Health, September 2020, Frontiers

    Professor Sandro Vento, Dr. Francesca Cainelli

  24. Acute liver failure

    Article • The Lancet, June 2020, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  25. Commentary: Systemic Lupus Erythematosus in Native sub-Saharan Africans: A Systematic Review and Meta-Analysis

    Article • Frontiers in Medicine, May 2020, Frontiers

    Professor Sandro Vento, Dr. Francesca Cainelli

  26. HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa

    Article • Frontiers in Medicine, May 2020, Frontiers

    Professor Sandro Vento, Dr. Francesca Cainelli

  27. Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population

    Article • Scientific Reports, February 2020, Springer Science + Business Media

    Professor Sandro Vento

  28. Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients

    Article • Frontiers in Medicine, February 2020, Frontiers

    Professor Sandro Vento, Dr. Francesca Cainelli

  29. Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients

    Article • AIDS, August 2019, Wolters Kluwer Health

    Professor Sandro Vento

  30. DRIVE-AHEAD Trial’s Results and the Need for a More Appropriate Comparator Drug

    Article • Clinical Infectious Diseases, May 2019, Oxford University Press (OUP)

    Professor Sandro Vento

  31. Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

    Article • Infectious Diseases, May 2019, Taylor & Francis

    Professor Sandro Vento

  32. Orphan drugs

    Article • The Lancet, April 2019, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  33. Khat-related liver disease in sub-Saharan Africa: neglected, yet important – Authors' reply

    Article • The Lancet Global Health, March 2019, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  34. Patient-centered Care and Treatment in HIV Infection

    Article • EClinicalMedicine, December 2018, Elsevier

    Professor Sandro Vento

  35. Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA?

    Article • Infectious Diseases, October 2018, Taylor & Francis

    Professor Sandro Vento, Sebastiano Rizzardo

  36. Defensive medicine: It is time to finally slow down an epidemic

    Article • World Journal of Clinical Cases, October 2018, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Sandro Vento, Dr. Francesca Cainelli

  37. Liver cirrhosis in sub-Saharan Africa: neglected, yet important

    Article • The Lancet Global Health, October 2018, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  38. “High” antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART

    Article • Infectious Diseases, June 2018, Taylor & Francis

    Professor Sandro Vento, Sebastiano Rizzardo

  39. Detection of Hepatitis E Antibodies in Kazakhstan: A Pilot Study

    Article • Central Asian Journal of Global Health, February 2018, University Library System, University of Pittsburgh

    Professor Sandro Vento, Dr. Francesca Cainelli

  40. The Expanding Therapeutic Perspective of CCR5 Blockade

    Article • Frontiers in Immunology, January 2018, Frontiers

    Professor Sandro Vento

  41. Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life

    Article • International Journal of STD & AIDS, January 2018, SAGE Publications

    Professor Sandro Vento

  42. Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean to Calabria, Italy

    Article • International Journal of Infectious Diseases, October 2017, Elsevier

    Professor Sandro Vento

  43. Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV ‐1‐infected patients

    Article • HIV Medicine, May 2017, Wiley

    Professor Sandro Vento, Fabio Rigo

  44. Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up

    Article • Journal of Antimicrobial Chemotherapy, April 2017, Oxford University Press (OUP)

    Professor Sandro Vento

  45. Cerebral palsy: a multidisciplinary, integrated approach is essential

    Article • The Lancet Global Health, April 2017, Elsevier

    Professor Sandro Vento

  46. Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient

    Article • International Journal of STD & AIDS, October 2016, SAGE Publications

    Professor Sandro Vento

  47. End-stage liver disease in eastern Europe and central Asia: action is needed

    Article • The Lancet Gastroenterology & Hepatology, September 2016, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  48. Treatment of Acute Liver Failure in Resource-Constrained Settings without Transplantation Facilities Can Be Improved

    Article • Frontiers in Medicine, July 2016, Frontiers

    Professor Sandro Vento, Dr. Francesca Cainelli

  49. Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2016, Wolters Kluwer Health

    Professor Sandro Vento

  50. Tuberculosis-immune reconstitution inflammatory syndrome

    Article • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, May 2016, Elsevier

    Professor Sandro Vento

  51. Liver diseases in sub-Saharan Africa: the importance of dedicated public clinics

    Article • Liver International, November 2015, Wiley

    Professor Sandro Vento, Dr. Francesca Cainelli

  52. Understanding the HIV/AIDS Atripla drug components interaction with human plasma.

    Article • Journal of Analytical Toxicology, October 2015, Oxford University Press (OUP)

    Prof Kwenga Festus Sichilongo, Sedireng Mompati Ndolo, Professor Sandro Vento

  53. Liver disease in patients with HIV in sub-Saharan Africa

    Article • The Lancet HIV, October 2015, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  54. Raltegravir/nevirapine dual therapy at reduced doses as ‘maintenance’ treatment in virally suppressed HIV-infected patients

    Article • AIDS, August 2015, Wolters Kluwer Health

    Professor Sandro Vento

  55. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act

    Article • The Lancet Global Health, July 2015, Elsevier

    Professor Sandro Vento

  56. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study

    Article • Journal of Neurology, April 2015, Springer Science + Business Media

    Professor Sandro Vento

  57. Virological Efficacy of a Reduced Dose of Nevirapine in a Small Cohort of Suppressed HIV-1–Infected Patients

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2015, Wolters Kluwer Health

    Professor Sandro Vento

  58. Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up

    Article • Journal of the International AIDS Society, November 2014, Wiley

    Professor Sandro Vento

  59. Efavirenz dose reduction in HIV-infected patients

    Article • AIDS, November 2014, Wolters Kluwer Health

    Professor Sandro Vento

  60. Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up

    Article • Journal of Antimicrobial Chemotherapy, October 2014, Oxford University Press (OUP)

    Professor Sandro Vento

  61. Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

    Article • Digestive and Liver Disease, September 2014, Elsevier

    Dr Antonio Picardi, Professor Sandro Vento

  62. Management of chronic hepatitis B in children: An unresolved issue

    Article • Journal of Gastroenterology and Hepatology, April 2014, Wiley

    Professor Sandro Vento, Dr. Francesca Cainelli

  63. Comparative chromatography–mass spectrometry studies on the antiretroviral drug nevirapine—Analytical performance characteristics in human plasma determination

    Article • Journal of Chromatography B, January 2014, Elsevier

    Prof Kwenga Festus Sichilongo, Professor Sandro Vento

  64. Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy

    Article • Pan African Medical Journal, January 2014, Pan African Medical Journal

    Dr Julius C Mwita, Professor Sandro Vento

  65. A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2013, Wolters Kluwer Health

    Professor Sandro Vento

  66. Efficacy of a Reduced Dose of Darunavir/Ritonavir in a Small Cohort of Antiretroviral-Naïve HIV-Infected Patients

    Article • AIDS Patient Care and STDs, June 2013, Mary Ann Liebert Inc

    Professor Sandro Vento

  67. Cancer control in Africa: which priorities?

    Article • The Lancet Oncology, April 2013, Elsevier

    Professor Sandro Vento

  68. Limited Adherence to Antiretroviral Regimens in an Italian Cohort

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2013, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  69. Can HIV-1 viral interference be used therapeutically?

    Article • The Lancet Infectious Diseases, January 2013, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  70. Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries

    Article • Tropical Medicine & International Health, October 2012, Wiley

    Professor Sandro Vento, Dr. Francesca Cainelli

  71. Isoniazid preventive therapy in human immunodeficiency virus infection [Correspondence]

    Article • The International Journal of Tuberculosis and Lung Disease, April 2012, International Union Against Tuberculosis and Lung Disease

    Professor Sandro Vento

  72. Efavirenz dose reduction in HIV-infected patients

    Article • HIV Medicine, March 2012, Wiley

    Professor Sandro Vento

  73. Antiretroviral Therapy-Associated Diseases Are Common in the Long-Term

    Article • AIDS Research and Human Retroviruses, September 2011, Mary Ann Liebert Inc

    Professor Sandro Vento

  74. A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients

    Article • The Brazilian Journal of Infectious Diseases, September 2011, Elsevier

    Professor Sandro Vento

  75. Efficacy of Lopinavir-Ritonavir Reduced Dose in HIV-Infected Patients

    Article • AIDS Patient Care and STDs, August 2011, Mary Ann Liebert Inc

    Professor Sandro Vento

  76. Tuberculosis and cancer: a complex and dangerous liaison

    Article • The Lancet Oncology, June 2011, Elsevier

    Professor Sandro Vento

  77. Stroke: a realistic approach to a growing problem in sub-Saharan Africa is urgently needed

    Article • Tropical Medicine & International Health, March 2011, Wiley

    Professor Sandro Vento

  78. Can antiretroviral therapy be safely interrupted and, if so, when?

    Article • HIV Medicine, December 2010, Wiley

    Professor Sandro Vento

  79. Silica Exposure and Silicosis: Action is Needed Now

    Article • Southern Medical Journal, November 2010, Southern Medical Association

    Professor Sandro Vento, Dr. Francesca Cainelli

  80. Antiretroviral therapy in low-resource settings

    Article • The Lancet, October 2010, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  81. Time for universal HIV and HBV screening for patients with cancer

    Article • The Lancet Oncology, October 2010, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  82. Editorial: [Challenges in Infectious Diseases in Low and Middle-Income Countries]

    Article • The Open Infectious Diseases Journal, September 2010, Bentham Science Publishers

    Professor Sandro Vento

  83. The challenge of lymphomas in sub-Saharan Africa

    Article • The Lancet Oncology, July 2010, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  84. PriorMycobacterium aviumcomplex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy

    Article • HIV Medicine, March 2010, Wiley

    Professor Sandro Vento

  85. Lymph nodes and pathogenesis of infection with HIV-1

    Article • The Lancet Infectious Diseases, February 2010, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  86. The need for new antibiotics

    Article • The Lancet, February 2010, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  87. No Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected Patients

    Article • AIDS Research and Human Retroviruses, August 2009, Mary Ann Liebert Inc

    Professor Sandro Vento

  88. The bacterium that could cause cancer

    Article • The Lancet Oncology, May 2009, Elsevier

    Professor Sandro Vento

  89. Diagnosis, management and outcome of clinically- suspected spinal infection

    Article • Journal of Infection, April 2009, Elsevier

    Professor Sandro Vento

  90. Maraviroc and CD4+ cell count recovery in patients with virologic suppression and blunted CD4+ cell response

    Article • AIDS, April 2009, Wolters Kluwer Health

    Professor Sandro Vento

  91. Human herpesvirus type 6 hepatitis or familiar intrahepatic cholestasis: the importance of follow-up

    Article • BMJ Case Reports, February 2009, BMJ

    Professor Sandro Vento

  92. Viral Encephalitis: Etiology, Clinical Features, Diagnosis and Management

    Article • The Open Infectious Diseases Journal, February 2009, Bentham Science Publishers

    Professor Sandro Vento, Dr. Francesca Cainelli

  93. Micafungin - The newest echinocandin

    Article • January 2009, Prous Science

    Professor Sandro Vento

  94. Letter to the Editor: Darunavir-Etravirine-Raltegravir as Salvage Combination Therapy in a Heavily Pretreated HIV-Infected Patient

    Article • AIDS Patient Care and STDs, November 2008, Mary Ann Liebert Inc

    Professor Sandro Vento

  95. Perspectives in therapy for hepatitis C

    Article • Expert Opinion on Investigational Drugs, October 2008, Informa Healthcare

    Professor Sandro Vento, Dr. Francesca Cainelli

  96. Lung infections after cancer chemotherapy

    Article • The Lancet Oncology, October 2008, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  97. Aminotransferases as predictors of mortality

    Article • The Lancet, May 2008, Elsevier

    Professor Sandro Vento

  98. Does tenofovir increase efavirenz hepatotoxicity?

    Article • AIDS, May 2008, Wolters Kluwer Health

    Professor Sandro Vento

  99. Initial Hospitalization and Adherence to Highly Active Antiretroviral Therapy

    Article • Clinical Infectious Diseases, March 2008, Oxford University Press (OUP)

    Professor Sandro Vento

  100. Voluntary or Universal HIV Testing in Italy?

    Article • Clinical Infectious Diseases, February 2008, Oxford University Press (OUP)

    Professor Sandro Vento

  101. Etravirine

    Article • Drugs of Today, January 2008, Prous Science

    Professor Sandro Vento

  102. Life-threatening, Multiple Hypersensitivity Reactions Induced by Rifampicin in One Patient with Pulmonary Tuberculosis

    Article • Southern Medical Journal, August 2007, Southern Medical Association

    Professor Sandro Vento

  103. Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption

    Article • AIDS, June 2007, Wolters Kluwer Health

    Professor Sandro Vento

  104. Selective Drug Taking During Combination Antiretroviral Therapy

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2007, Wolters Kluwer Health

    Professor Sandro Vento

  105. Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis

    Article • International Journal of STD & AIDS, February 2007, SAGE Publications

    Professor Sandro Vento

  106. Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults

    Article • The Lancet Infectious Diseases, August 2006, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  107. Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl

    Article • European Journal of Gastroenterology & Hepatology, August 2006, Wolters Kluwer Health

    Professor Sandro Vento

  108. Tenofovir-Associated Kidney Diseases and Interactions between Tenofovir and Other Antiretrovirals

    Article • Clinical Infectious Diseases, June 2006, Oxford University Press (OUP)

    Professor Sandro Vento

  109. Infections and thalassaemia

    Article • The Lancet Infectious Diseases, April 2006, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  110. Hyperacute Unilateral Gonococcal Endophthalmitis in an HIV-Infected Man without Genital Infection

    Article • European Journal of Ophthalmology, March 2006, SAGE Publications

    Professor Sandro Vento

  111. Clinical course of infection with hepatitis C

    Article • BMJ, February 2006, BMJ

    Professor Sandro Vento, Dr. Francesca Cainelli

  112. Human Immunodeficiency Virus-Associated Peripheral Neuropathies

    Article • Mayo Clinic Proceedings, February 2006, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  113. Interleukin-2 therapy and CD4+ T cells in HIV-1 infection

    Article • The Lancet, January 2006, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  114. Acute liver failure as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection

    Article • Journal of Gastroenterology and Hepatology, January 2006, Wiley

    Professor Sandro Vento

  115. CHILDHOOD HEPATITIS C VIRUS INFECTION.

    Article • Journal of Gastroenterology and Hepatology, December 2005, Wiley

    Professor Sandro Vento, Dr. Francesca Cainelli

  116. Recreational substance use and tolerance of efavirenz in HIV-1 infected patients

    Article • AIDS Care, October 2005, Taylor & Francis

    Professor Sandro Vento

  117. Cutaneous abscess due to in injection drug user: a case report and review of the literature

    Article • Journal of Infection, August 2005, Elsevier

    Professor Sandro Vento

  118. Strongyloidiasis in an HIV‐1–Infected Patient after Highly Active Antiretroviral Therapy–Induced Immune Restoration

    Article • The Journal of Infectious Diseases, March 2005, Oxford University Press (OUP)

    Professor Sandro Vento

  119. Tipranavir

    Article • Drugs of Today, January 2005, Prous Science

    Professor Sandro Vento, Dr. Francesca Cainelli

  120. Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus

    Article • Annals of the Rheumatic Diseases, December 2004, BMJ

    Professor Sandro Vento, Dr. Francesca Cainelli

  121. Can We Really Identify HIV-1 Long-Term Nonprogressors?

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2004, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  122. Painful Neuropathy Vasculitis in 2 Patients with Long-Standing Human Immunodeficiency Virus-1 Infection

    Article • Scandinavian Journal of Infectious Diseases, May 2004, Taylor & Francis

    Professor Sandro Vento

  123. Early detection of lung cancer in high-risk patients with HIV-1 infection

    Article • International Journal of STD & AIDS, March 2004, SAGE Publications

    Professor Sandro Vento

  124. Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection

    Article • The Pediatric Infectious Disease Journal, February 2004, Wolters Kluwer Health

    Professor Sandro Vento

  125. Is there a role for viruses in triggering autoimmune hepatitis?

    Article • Autoimmunity Reviews, January 2004, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  126. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment

    Article • The Lancet Oncology, October 2003, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  127. Is there a role for TNF-alpha in HIV1-associated lipodystrophy?

    Article • European Journal of Clinical Investigation, August 2003, Wiley

    Professor Sandro Vento

  128. Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman

    Article • British Journal of Dermatology, July 2003, Wiley

    Professor Sandro Vento

  129. Management of Health Care Workers With Blood-Borne Infections

    Article • Archives of Internal Medicine, June 2003, American Medical Association (AMA)

    Professor Sandro Vento

  130. Hepatitis C virus in people with HIV infection

    Article • The Lancet, December 2002, Elsevier

    Professor Sandro Vento

  131. Blood-Borne Viruses and Health Care Workers

    Article • Archives of Internal Medicine, October 2002, American Medical Association (AMA)

    Professor Sandro Vento

  132. Sequelae and Serologic Outcome in Persons with Hepatitis B Virus Infection

    Article • Annals of Internal Medicine, October 2002, American College of Physicians

    Professor Sandro Vento, Dr. Francesca Cainelli

  133. Erratum

    Article • The Lancet Infectious Diseases, October 2002, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  134. Infections and solid organ transplant rejection: a cause-and-effect relationship?

    Article • The Lancet Infectious Diseases, September 2002, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  135. Hepatitis C is not a sexually transmissible disease

    Article • The American Journal of Gastroenterology, July 2002, Wolters Kluwer Health

    Professor Sandro Vento

  136. Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection

    Article • AIDS, July 2002, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  137. Treatment of autoantibody-associated chronic hepatitis C

    Article • The American Journal of Gastroenterology, July 2002, Wolters Kluwer Health

    Professor Sandro Vento

  138. Hepatitis C is not a sexually transmissible disease

    Article • The American Journal of Gastroenterology, July 2002, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  139. Treatment of autoantibody-associated chronic hepatitis C

    Article • The American Journal of Gastroenterology, July 2002, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  140. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue

    Article • The Lancet Oncology, June 2002, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  141. Childhood Infections and Autoimmune Diseases

    Article • New England Journal of Medicine, May 2002, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento, Dr. Francesca Cainelli

  142. Does hepatitis C virus cause severe liver disease only in people who drink alcohol?

    Article • The Lancet Infectious Diseases, May 2002, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  143. How tainted is medicine?

    Article • The Lancet, May 2002, Elsevier

    Professor Sandro Vento

  144. Full Adherence to HAART: Is It Really Necessary?

    Article • Archives of Internal Medicine, April 2002, American Medical Association (AMA)

    Professor Sandro Vento, Dr. Francesca Cainelli

  145. BCG efficacy and tuberculin skin testing

    Article • The Lancet, April 2002, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  146. A Case of Visceral Leishmaniasis with Protracted Incubation in a Nonendemic Area

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 2001, Springer Science + Business Media

    Professor Sandro Vento, Dr. Francesca Cainelli

  147. Mortality Due to Hepatitis C Virus–Related Cirrhosis in Patients Infected with HIV Type 1: A Role for Alcohol

    Article • Clinical Infectious Diseases, November 2001, Oxford University Press (OUP)

    Professor Sandro Vento, Dr. Francesca Cainelli

  148. MHC Class I Molecules and Progression to AIDS

    Article • New England Journal of Medicine, September 2001, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento, Dr. Francesca Cainelli

  149. Hepatitis A Virus Infection and Atherosclerosis

    Article • The Journal of Infectious Diseases, August 2001, Oxford University Press (OUP)

    Professor Sandro Vento, Dr. Francesca Cainelli

  150. Isolated Presence of Antibody to Hepatitis B Core Antigen in Injection Drug Users: Do They Need to Be Vaccinated?

    Article • Clinical Infectious Diseases, May 2001, Oxford University Press (OUP)

    Professor Sandro Vento

  151. Tuberculous chorioretinitis

    Article • The Lancet, May 2001, Elsevier

    Professor Sandro Vento

  152. Failure of lamivudine therapy for chemotherapy-induced reactivation of Hepatitis B

    Article • The American Journal of Gastroenterology, May 2001, Wolters Kluwer Health

    Professor Sandro Vento

  153. No Increase in Liver Decompensation Risk with Atypical Hepatitis C Virus Antibody Pattern

    Article • The Journal of Infectious Diseases, May 2001, Oxford University Press (OUP)

    Professor Sandro Vento, Dr. Francesca Cainelli

  154. Failure of lamivudine therapy for chemotherapy-induced reactivation of Hepatitis B

    Article • The American Journal of Gastroenterology, May 2001, Wolters Kluwer Health

    Professor Sandro Vento, Dr. Francesca Cainelli

  155. HIV-1 progression in hepatitis-C-infected drug users

    Article • The Lancet, April 2001, Elsevier

    Professor Sandro Vento, Dr. Vicente Soriano, Dr. Francesca Cainelli

  156. Effect of pregnancy on chronic hepatitis C

    Article • The Lancet, February 2001, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  157. Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis

    Article • British Journal of Dermatology, December 2000, Wiley

    Professor Sandro Vento, Dr. Francesca Cainelli

  158. Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2000, Springer Science + Business Media

    Professor Sandro Vento

  159. Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes

    Article • Diabetes Care, July 2000, American Diabetes Association

    Professor Sandro Vento, Dr. Francesca Cainelli

  160. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C

    Article • Journal of Viral Hepatitis, April 2000, Wiley

    Professor Sandro Vento

  161. Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy

    Article • Journal of Infection, November 1999, Elsevier

    Professor Sandro Vento

  162. Mediastinal Lymphadenitis due To Cryptococcal Infection In HIV-Positive Patients On Highly Active Antiretroviral Therapy

    Article • CHEST Journal, September 1999, Elsevier

    Professor Sandro Vento

  163. Correspondence

    Article • The American Journal of Gastroenterology, July 1999, Wolters Kluwer Health

    Professor Sandro Vento

  164. Adherence to HAART in HIV

    Article • The Lancet, March 1999, Elsevier

    Professor Sandro Vento

  165. Failure of Prophylaxis against PCP in Patients with HIV Infection

    Article • AIDS Patient Care and STDs, November 1998, Mary Ann Liebert Inc

    Professor Sandro Vento

  166. Hepatitis Associated with Hepatitis A Superinfection in Patients with Chronic Hepatitis C

    Article • New England Journal of Medicine, June 1998, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento

  167. Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands

    Article • Acta Tropica, June 1998, Elsevier

    Professor Sandro Vento

  168. Highly active antiretroviral therapy

    Article • The Lancet, April 1998, Elsevier

    Professor Sandro Vento

  169. Fluconazole penetration into the prostatic fluid of patients with AIDS- associated cryptococcal meningitis

    Article • Journal of Antimicrobial Chemotherapy, March 1998, Oxford University Press (OUP)

    Professor Sandro Vento

  170. Syphilis in prostitutes from Eastern Europe

    Article • The Lancet, February 1998, Elsevier

    Professor Sandro Vento

  171. Tuberculosis Among Refugees and Displaced People at the Burundi‐Rwanda Border

    Article • Clinical Infectious Diseases, February 1998, Oxford University Press (OUP)

    Professor Sandro Vento

  172. Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

    Article • New England Journal of Medicine, January 1998, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento, Dr. Francesca Cainelli

  173. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance

    Article • The Lancet, November 1997, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  174. Microsporidium Species in Pulmonary Cavity Lesions of AIDS Patient Infected withRhodococcus equi

    Article • Clinical Infectious Diseases, October 1997, Oxford University Press (OUP)

    Professor Sandro Vento

  175. Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS

    Article • Journal of Infection, September 1997, Elsevier

    Professor Sandro Vento

  176. The ParaSight™-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, July 1997, Oxford University Press (OUP)

    Professor Sandro Vento

  177. Aetiology of pneumonia following isolated closed head injury

    Article • Respiratory Medicine, April 1997, Elsevier

    Professor Sandro Vento

  178. Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C

    Article • Journal of Hepatology, April 1997, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  179. Infection with hepatitis G virus in immunoglobulin recipients

    Article • The Lancet, January 1997, Elsevier

    Professor Sandro Vento

  180. M tuberculosis drug resistance in AIDS

    Article • The Lancet, January 1997, Elsevier

    Professor Sandro Vento

  181. Resolution of autoimmune hepatitis after bone-marrow transplantation

    Article • The Lancet, August 1996, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  182. Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data

    Article • Clinical Microbiology and Infection, August 1996, Elsevier

    Professor Sandro Vento

  183. Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients

    Article • Tubercle and Lung Disease, June 1996, Elsevier

    Professor Sandro Vento

  184. Lack of Sustained Efficacy of Interferon in Patients with Chronic Hepatitis C

    Article • New England Journal of Medicine, May 1996, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento

  185. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

    Article • The Lancet, January 1996, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  186. Discordant Manifestations of Hepatitis C in Monozygotic Twins

    Article • New England Journal of Medicine, November 1995, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento

  187. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals

    Article • The Lancet, September 1995, Elsevier

    Professor Sandro Vento, Dr. Francesca Cainelli

  188. Naturally acquired immunity to Plasmodium falciparum

    Article • Parasitology Today, September 1995, Elsevier

    Professor Sandro Vento

  189. Multidrug-Resistant Tuberculosis in Patients With AIDS

    Article • Archives of Internal Medicine, July 1995, American Medical Association (AMA)

    Professor Sandro Vento

  190. Multidrug-resistant tuberculosis in patients with AIDS

    Article • Archives of Internal Medicine, July 1995, American Medical Association (AMA)

    Professor Sandro Vento

  191. Pentoxifylline as a Supportive Agent in the Treatment of Cerebral Malaria in Children

    Article • The Journal of Infectious Diseases, May 1995, Oxford University Press (OUP)

    Professor Rocco Micciolo, Professor Sandro Vento

  192. West African Immigrants and New Patterns of Malaria Imported to North Eastern Italy

    Article • Journal of Travel Medicine, September 1994, Oxford University Press (OUP)

    Professor Sandro Vento

  193. Manifestations of TB to CD4 cell counts.

    Article • American Journal of Respiratory and Critical Care Medicine, August 1994, American Thoracic Society

    Professor Sandro Vento

  194. Prognosis of vertically transmitted pre-core mutant HBV infection

    Article • The Lancet, April 1994, Elsevier

    Professor Sandro Vento

  195. Pneumocystis carinii pneumonia during primary HIV-1 infection

    Article • The Lancet, July 1993, Elsevier

    Professor Sandro Vento

  196. Rapid decline of CD4+ cells after IFNα treatment in HIV-1 infection

    Article • The Lancet, April 1993, Elsevier

    Professor Sandro Vento

  197. Transmission of HIV-Associated Tuberculosis to Healthcare Workers

    Article • Infection Control and Hospital Epidemiology, February 1993, Cambridge University Press

    Professor Rocco Micciolo, Professor Sandro Vento

  198. Hepatitis C viraemia with normal liver histology in symptomless HIV-1 infection

    Article • The Lancet, November 1992, Elsevier

    Professor Sandro Vento

  199. Use of fluconazole in the treatment ofCandida albicans hydrocephalus shunt infection

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 1992, Springer Science + Business Media

    Professor Sandro Vento

  200. Failure of the 12 months course of antituberculous chemoprophylaxis in HIV infection

    Article • Journal of Infection, January 1992, Elsevier

    Professor Sandro Vento

  201. Tuberculosis and HIV Infection

    Article • New England Journal of Medicine, December 1991, New England Journal of Medicine (NEJM/MMS)

    Professor Sandro Vento

  202. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals

    Article • The Lancet, May 1991, Elsevier

    Professor Sandro Vento

  203. Survival after Active Tuberculosis in Patients with HIV Infection

    Article • American Review of Respiratory Disease, July 1990, American Thoracic Society

    Professor Sandro Vento

  204. Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis

    Article • Springer Seminars in Immunopathology, May 1990, Springer Science + Business Media

    Professor Sandro Vento

  205. Type 2 autoimmune hepatitis and hepatitis C virus infection

    Article • The Lancet, April 1990, Elsevier

    Professor Sandro Vento

  206. HAZARDS OF INTERFERON THERAPY FOR HBV-SERONEGATIVE CHRONIC HEPATITIS

    Article • The Lancet, October 1989, Elsevier

    Professor Sandro Vento

  207. REACTIVATION OF HEPATITIS B IN AIDS

    Article • The Lancet, July 1989, Elsevier

    Professor Sandro Vento

  208. CLINICAL REACTIVATION OF HEPATITIS B IN ANTI-HBs-POSITIVE PATIENTS WITH AIDS

    Article • The Lancet, February 1989, Elsevier

    Professor Sandro Vento

  209. PATHOGENESIS OF TYPE I DIABETES

    Article • The Lancet, November 1988, Elsevier

    Professor Sandro Vento

  210. Serial study of liver-directed autoantibodies and autoreactive T-lymphocytes in acute viral hepatitis B

    Article • Journal of Autoimmunity, June 1988, Elsevier

    Professor Sandro Vento

  211. Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase

    Article • Journal of Medical Virology, February 1988, Wiley

    Professor Sandro Vento

  212. In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis

    Article • International Journal of Immunopharmacology, January 1988, Elsevier

    Professor Sandro Vento

  213. Relevance of immune mediated mechanisms in progressive alcoholic liver injury

    Article • Molecular Aspects of Medicine, January 1988, Elsevier

    Professor Sandro Vento

  214. PROSPECTIVE STUDY OF CELLULAR IMMUNITY TO HEPATITIS-B-VIRUS ANTIGENS FROM THE EARLY INCUBATION PHASE OF ACUTE HEPATITIS B

    Article • The Lancet, July 1987, Elsevier

    Professor Sandro Vento

  215. T-CELL INDUCERS OF SUPPRESSOR LYMPHOCYTES CONTROL LIVER-DIRECTED AUTOREACTIVITY

    Article • The Lancet, April 1987, Elsevier

    Professor Sandro Vento

  216. CELL-MEDIATED IMMUNITY AND SUPPRESSOR-T-CELL DEFECTS TO LIVER-DERIVED ANTIGENS IN FAMILIES OF PATIENTS WITH AUTOIMMUNE CHRONIC ACTIVE HEPATITIS

    Article • The Lancet, February 1986, Elsevier

    Professor Sandro Vento

  217. T lymphocyte sensitization to hbcag and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease

    Article • Hepatology, March 1985, Wiley

    Professor Sandro Vento

  218. ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS

    Article • The Lancet, June 1984, Elsevier

    Professor Sandro Vento